top of page

Preserve your uterus with scarless procedure

Imagine a life without fibroids!

Transforming women's health through empathetic innovation


Uterine fibroids are non-cancerous tumors affecting 1 in 4 women globally, causing substantial quality of life issues. Economic burden globally is about $34 Billion.

What we do


Nesa Medtech's mission is to transform women’s health by developing a revolutionary minimally invasive surgical solutions by pursuing innovation through technology while adhering to global quality standards with support of a multi disciplinary and experienced team. 

Nesa’s flagship product GYIDE is a novel minimally invasive, safe, effective and uterus-preserving technology to treat uterine fibroids.

​Existing Solutions - Invasive or Inaccessible

Non Surgical
Cutting & Suturing
Longer Recovery
Operation Theater
Interventional Radiologist
No Cut & Suture
Longer Procedure Time 
Expensive Infrastructure



Our Solution

GYIDE addresses the primary concern of key stakeholders and offers an effective alternative to current solutions.

Our innovative technology is a precise guidance and planning system to deliver treatment to shrink uterine fibroids leading to symptomatic relief.

Revolutionary scarless technology to treat uterine fibroids.

Faster Recovery

Less Procedure Time

No Cut, No Suturing

Uterus Preservation

N Logo  Outline PNG.png

Strong and Prolonged


Severe Abdominal 



Primary Symptom Heavy menstrual bleeding²

Waiting time to seek treatment¹

Employed women missed work¹

1. Bijan J, Borah. Am J Obstet Gynecol 2013 Oct 209(4):319.e1-319.e2 2. De La Cruz MS, Buchana EM. Am Fam Physician 2017;95(2) 100-107

bottom of page